Lrig1 antibody (AA 35-220)
Quick Overview for Lrig1 antibody (AA 35-220) (ABIN6143319)
Target
See all Lrig1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 35-220
-
Sequence
- AGPRAPCAAA CTCAGDSLDC GGRGLAALPG DLPSWTRSLN LSYNKLSEID PAGFEDLPNL QEVYLNNNEL TAVPSLGAAS SHVVSLFLQH NKIRSVEGSQ LKAYLSLEVL DLSLNNITEV RNTCFPHGPP IKELNLAGNR IGTLELGAFD GLSRSLLTLR LSKNRITQLP VRAFKLPRLT QLDLNR
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 35-220 of human LRIG1 (NP_056356.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:1000 - 1:2000
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
Alternative Name
- LRIG1
-
Background
- Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,LRIG1,LIG-1,LIG1,Cancer,Tumor suppressors,LRIG1
-
Molecular Weight
- 116 kDa/119 kDa
-
Gene ID
- 26018
-
UniProt
- Q96JA1
Target
-